688139 海爾生物
按盤價 
34.530 +0.780 (+2.311%) | 2024/09 - 九個月 人民幣(K¥) | 與去年同期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | ||
| 營業總收入 | 1,782,020 | -2.43% | 2,280,896 | 2,864,045 | 2,125,863 | 1,402,029 | |
| 減：營業總成本 | 1,468,536 | -3.93% | 1,966,937 | 2,293,396 | 1,688,316 | 1,082,247 | |
| 其中:營業成本 | 917,520 | -1.47% | 1,125,978 | 1,484,881 | 1,059,842 | 694,110 | |
| 財務費用 | (33,895) | 127.60% | (23,532) | (20,279) | (11,883) | (14,367) | |
| 資產減值損失 | (1,755) | 20.23% | (1,643) | (5,410) | (1,328) | (1,360) | |
| 公允價值變動收益 | (173) | -95.81% | 2,056 | (7,007) | 10,208 | 3,831 | |
| 投資收益 | 16,606 | -77.36% | 83,033 | 74,721 | 473,267 | 89,962 | |
| 其中：對聯營企業和合營企業的投資收益 | 4,506 | 15.49% | 8,173 | 8,963 | 14,193 | 26,828 | |
| 營業利潤 | 340,805 | -13.76% | 438,401 | 675,680 | 961,434 | 427,548 | |
| 利潤總額 | 342,418 | -12.56% | 434,491 | 675,336 | 960,871 | 424,236 | |
| 減：所得稅費用 | 23,441 | -9.76% | 22,433 | 63,362 | 111,701 | 40,112 | |
| 淨利潤 | 318,978 | -12.76% | 412,059 | 611,974 | 849,170 | 384,123 | |
| 減：非控股權益 | 9,836 | 16.48% | 5,985 | 11,183 | 4,135 | 3,169 | |
| 股東淨利潤 | 309,142 | -13.45% | 406,074 | 600,791 | 845,035 | 380,954 | |
市場價值指標 | |||||||
| 每股收益 (元) * | 0.980 | -13.27% | 1.280 | 1.890 | 2.670 | 1.200 | |
| 每股派息 (元) * | -- | -- | 0.515 | 0.450 | 0.500 | 0.380 | |
| 每股淨資產 (元) * | 13.529 | 2.24% | 13.306 | 12.645 | 11.426 | 8.755 | |
| 審計意見 # | -- | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | 标准无保留意见 | ||
| 備註： | *未調整數據 |
| #只提供簡體內容 | |
| 即時報價更新時間為 19/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
